Anthracycline-Based Combination Chemotherapy (Doxorubicin and Dacarbazine) For the Desmoid Tumor in a Neoadjuvant Setting. Report of a Case
Divyanshu Dua* & Mahmood Shahid
Department of Medical Oncology, The Canberra Hospital, Australian National University, Australia
Dr. Divyanshu Dua, Department of Medical Oncology, The Canberra Hospital, Australian National University, Australia.
Keywords: Chemotherapy; Desmoid Tumors; Ultrasound
We report a case of a 41-year-old female with a sporadic abdominal wall desmoid tumor. After a period of 12-month observation, chemotherapy was given with Doxorubicin and Dacarbazine to facilitate minimal surgery. The patient received 4 cycles of chemotherapy. Treatment was well tolerated and resulted in a significant reduction of the tumor size from 48mm to 25mm, 48% reduction. The tumor was surgically resected, and the histopathology from the resected specimen revealed a partial pathological response. At 6 months post-surgery, there is no recurrence or surgical complications.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).